financetom
Business
financetom
/
Business
/
Cadbury India Tax fraud: CBI books company for illegally obtaining factory licence in 2007
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cadbury India Tax fraud: CBI books company for illegally obtaining factory licence in 2007
Mar 19, 2021 2:52 PM

The Central Bureau of Investigation (CBI) recently filed a tax fraud case against Cadbury India, for alleged misappropriation of facts for tax benefits for a factory licence in Baddi, Himachal Pradesh.

Share Market Live

NSE

The case was registered under IPC Section 420 (Forgery) and the Prevention of Corruption Act. CBI registered the FIR after carrying out a preliminary enquiry.

The FIR against Cadbury India, which is currently known as Mondelez Foods, said that some members of the then executive board of the company and key managers forged records and bribed authorities to cover up evidence that came up during an investigation.

On March 17, CBI carried out searches at locations in Himachal Pradesh, Mohali and Mumbai. Economic Times reported that the company managed to get area-based exemptions of around Rs 240 crore for the Himachal factory.

The hilly state has special benefits for new industrial units under which companies can opt not to pay excise duties for up to 10 years. The CBI said that Cadbury India was not entitled for these benefits. The factory was set up in 2005 for manufacturing Bournvita.

Cadbury had proposed to create the Baddi factory in 2007 for the exemption. The CBI said the company later decided to only expand a unit that was built in 2005.

Around 12 individuals have been booked by the CBI, including senior executives of Cadbury India. The probe agency alleged that the firm's executives and certain individuals made illegal payments to obtain certain approvals for which they were not eligible.

(Edited by : Jerome)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing
Celldex Therapeutics Insider Sold Shares Worth $1,586,844, According to a Recent SEC Filing
Jun 11, 2024
04:09 PM EDT, 06/11/2024 (MT Newswires) -- Diane C. Young, Senior Vice President, Chief Medical Officer, on June 07, 2024, sold 45,000 shares in Celldex Therapeutics ( CLDX ) for $1,586,844. Following the Form 4 filing with the SEC, Young has control over a total of 2,115 shares of the company, with 2,115 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/744218/000141588924016344/xslF345X03/form4-06112024_080650.xml ...
--Rubrik Guides For FY 2025 EPS Loss of $2.35-$2.25 on Revenue of $810-$824 Million, vs CIQ Analyst Consensus of $2.35/Share Loss on Revenue of $806 Million
--Rubrik Guides For FY 2025 EPS Loss of $2.35-$2.25 on Revenue of $810-$824 Million, vs CIQ Analyst Consensus of $2.35/Share Loss on Revenue of $806 Million
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Price: 37.00, Change: +1.71, Percent Change: +4.85 ...
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing
Celldex Therapeutics Insider Sold Shares Worth $525,873, According to a Recent SEC Filing
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer, on June 07, 2024, sold 15,000 shares in Celldex Therapeutics ( CLDX ) for $525,873. Following the Form 4 filing with the SEC, Crowley has control over a total of 9,074 shares of the company, with 9,074 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/744218/000141588924016345/xslF345X03/form4-06112024_080653.xml ...
Onto Innovation Insider Sold Shares Worth $317,112, According to a Recent SEC Filing
Onto Innovation Insider Sold Shares Worth $317,112, According to a Recent SEC Filing
Jun 11, 2024
04:08 PM EDT, 06/11/2024 (MT Newswires) -- Srinivas Vedula, Senior Vice President, Customer Success, on June 10, 2024, sold 1,486 shares in Onto Innovation ( ONTO ) for $317,112. Following the Form 4 filing with the SEC, Vedula has control over a total of 17,433 shares of the company, with 17,433 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/704532/000202285924000025/xslF345X03/edgardoc.xml Price: 218.36, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved